Price Alert

Pharming Group N.V. (PHAR)

NASDAQ: PHAR · Real-Time Price · USD

14.60

-0.27 (-1.82%)

At close: Sep 05, 2025, 3:59 PM

14.50

-0.68%

After-hours: Sep 05, 2025, 06:26 PM EDT

-1.82% (1D)

Bid	14
Market Cap	984.45M
Revenue (ttm)	341.2M
Net Income (ttm)	-8.24M
EPS (ttm)	-0.14
PE Ratio (ttm)	-104.29
Forward PE	-743.5
Analyst	Buy

Ask	16.33
Volume	21,303
Avg. Volume (20D)	7,606
Open	15.18
Previous Close	14.87
Day's Range	14.43 - 15.60
52-Week Range	6.73 - 17.08
Beta	0.59

About PHAR

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol PHAR

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for PHAR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Pharming Group N.V. is scheduled to release its earnings on Oct 23, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

+10.11%

Pharming shares are trading higher after the compa... Unlock content with Pro Subscription

5 months ago

+12.92%

Pharming Group shares are trading higher after the company reported Q4 financial results and beat its EPADS and sales estimates.

News

2 weeks ago · zacks.com

Wall Street Analysts See a 142.26% Upside in Pharming Group (PHAR): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 142.3% in Pharming Group (PHAR). While the effectiveness of this highly sought-after metric is questionable, th...

1 month ago · zacks.com

Wall Street Analysts Think Pharming Group (PHAR) Could Surge 145.75%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 145.8% in Pharming Group (PHAR). While the effectiveness of this highly sought-after metric is questionable, th...

1 month ago · seekingalpha.com

Pharming Group N.V. (PHAR) Q2 2025 Earnings Call Transcript

Pharming Group N.V. (NASDAQ:PHAR ) Q2 2025 Earnings Conference Call July 31, 2025 7:30 AM ET Executives Anurag Relan – Chief Medical Officer Fabrice Chouraqui – CEO & Executive Director Stephen Toor –...